Private company

Biostax Corp.

Last updated Oct 16, 2026.

Overview

IndustryPharmaceutical Preparations
HeadquartersFL
Incorporated inFL²
Business address2431 Aloma Ave #124, Winter Park, Fl 32792²
Filer categoryNon-accelerated filer, Smaller reporting company²

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2018

58.0%Gross margin³

-3599.0%Operating margin³

-7599.7%Net margin³

-$1.4MFree cash flow³

Where the money goes

Where each dollar of revenue went, fiscal 2018

Selling, general and admin

Cost of revenue1¢$47.7K
Research and development4¢$144.1K
Selling, general and admin94¢$3.2M

Out of $113.5K in revenue.³ The company lost money this year.

Financial statements

Operating income⁴³-$4.1M in 2018−31% since 2017

Net income⁵³-$8.6M in 2018+9% since 2017

Fiscal year	2017	2018
Revenue		$113.5K³
Cost of revenue		$47.7K³
Gross profit		$65.8K³
Research and development	$399.4K⁴	$144.1K³
Selling, general and admin	$2.8M⁴	$3.2M³
Operating income	-$5.9M⁴	-$4.1M³
Interest
Income tax
Net income	-$7.9M⁵	-$8.6M³
Earnings per share	-$0.02⁴	-$0.02⁴
Earnings per share (diluted)

Total assets⁴³$91.6K in 2018−53% since 2017

Total liabilities⁴³$11.3M in 2018+0% since 2017

Shareholders’ equity³⁹-$11.3M in 2018+1% since 2017

Cash⁴³$5.9K in 2018−60% since 2017

Fiscal year	2017	2018
Cash	$14.7K⁴	$5.9K³
Current assets	$192.8K⁴	$88.7K³
Total assets	$195.5K⁴	$91.6K³
Current liabilities	$11.3M⁴	$11.3M³
Total liabilities	$11.3M⁴	$11.3M³
Shareholders’ equity	-$11.1M³	-$11.3M⁹
Shares outstanding	386.8M shares⁴	434.3K shares³

Cash from operations⁴³-$1.4M in 2018−33% since 2017

Capital spending⁴³$2.0K in 2018+31% since 2017

Free cash flow⁴³-$1.4M in 2018−33% since 2017

Fiscal year	2017	2018
Cash from operations	-$2.1M⁴	-$1.4M³
Capital spending	$1.5K⁴	$2.0K³
Free cash flow	-$2.1M	-$1.4M

Compare Biostax Corp. with another company

Former names

Immune Therapeutics, Inc.Nov 14, 2014 to Sep 14, 2023²
TNI BIOTECH, INC.Oct 2, 2012 to Oct 30, 2014²

Recent filings

Apr 11, 202510-Q BIOSTAX CORP - FORM 10-Q SEC FILING
Feb 20, 20258-K BIOSTAX CORP. - FORM 8-K SEC FILING
Aug 19, 202410-Q/A
Aug 19, 202410-Q
Jul 5, 202410-K/A
May 20, 202410-Q
Apr 16, 202410-K
Nov 14, 202310-Q
Nov 14, 20238-K
Nov 2, 20238-K
Oct 24, 20238-K
Sep 14, 20238-K
Sep 13, 20238-K
Aug 18, 202310-Q
May 12, 202310-Q

Every filing from the last three years, summarized. The full record is on SEC EDGAR.¹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARBiostax Corp. filings on SEC EDGAR
2
SEC EDGARBiostax Corp. filings on SEC EDGAR
3
SEC EDGARBiostax Corp. 10-K for fiscal 2018
4
SEC EDGARBiostax Corp. 10-K for fiscal 2017
5
SEC EDGARBiostax Corp. 10-K for fiscal 2017
6
SEC EDGARBiostax Corp. 10-Q for fiscal 2023
7
SEC EDGARBiostax Corp. 10-Q for fiscal 2024
8
SEC EDGARBiostax Corp. 10-Q for fiscal 2024
9
SEC EDGARBiostax Corp. 10-K for fiscal 2018